Chongqing Pharmaceutical (Group) Co., Ltd. is the key backbone
subsidiary enterprise of SASAC in Chongqing and the holding
subsidiary of Chongqing Chemical & Pharmaceutical Holding (Group)
Company. Established in 1950, the predecessor of the Group ---
Southwest China Branch of Sinopharm is the key reserve organization
for medical instruments designated by the central government and
Chongqing government. It is also one of the only three enterprises
wholesaling special drugs nationwide. The Group, based on the
coordinated development of such three types of operation as
pharmaceutical business, big health and R&D of drug, is the
largest-scaled medical & healthcare group with the strongest
comprehensive strength in western China. The Group has 69 all-level
branches and subsidiaries and over 10,000 employees spreading over
12 provinces and cities of central-western China. In 2015, the
Group achieved 19,400,000,000 yuan in sales revenue and 800,000,000
yuan in taxation of profits, which ranked the first in western
China.
Pharmaceutical business of the Group covers the entire process of
selling in hospitals, wholesaling, chain retailing, terminal
distribution, warehouse logistics and supply chain value-added
services of drugs, medical equipment and health products. The Group
is engaged in drugs of more 80,000 specifications, maintains a
long-term stable cooperative relationship with over 10,000 upstream
and downstream customers. With its marketing network spreading all
over 34 provinces (cities and autonomous regions) in China, the
Group has established more than ten province-level pharmaceutical
business platforms in Sichuan, Chongqing, Yunnan, Guizhou, Hubei,
Hunan, Jiangxi, Shaanxi, Gansu, Ningxia, Qinghai and Xinjiang, etc.
The complex completely covering 35 districts and counties in
Chongqing has been achieved, which accounts for over 75% sales
quota of Grade III and Class A hospitals in Chongqing. By building
the “pharmaceutical + Internet” platform, the Group carries out
medical E-commerce, such as B2B, B2C and O2O, etc.; cooperates with
large-scaled general hospitals by means of hospital-acquired
intelligent logistics technology, so as to enable the warehouse to
move forward; constructs central storeroom through complementary
advantages of medium-/small-sized hospitals and regional medical
centers, so as to achieve centralized distribution.
The nationally-known brand “peace drugstore” subordinated to the
Group possesses 559 direct-sale stores distributed in Sichuan,
Chongqing and Guizhou, “Peace Global Purchase” cross-border
E-commerce platform and Peace Drugstore E-shop; meanwhile, the
Group carries out such businesses as setting up hospital-acquired
self-paying drugstores, direct to patient (DTP) and hospital
injection center, etc. with multiple hospitals. With leading
large-scaled modern pharmaceutical logistics center in China, the
Group has built 42 domestic sub-distribution centers with 100,000
square meters in warehouse space.
The big health sector of the Group exerts it self to create
structured distinctive diagnosis and treatment system which
concerns provision for the aged, health maintenance, recovery,
physical examination and other fields combining medical resources
with endowment resources, collocates and participates in reforms of
several public hospitals in the city, jointly establishes auxiliary
reproductive health specialized hospitals and high-end physical
examination center with grade 3 and class A hospitals, and spares
no efforts to lay out the chain community clinics. Aiming at the
accurate direction of medical development, the Group builds the
first large-scaled professional biology laboratory for clinical
cell molecular genetics to provide services of gene sequencing and
detection.
With regard to R&D of drug, the Group and Chongqing Institute
of Green and Intelligent Technology, Chinese Academy of Sciences
jointly establish Chongqing Bio-pharmaceutical Institute and carry
out in-depth cooperative R&D and put achievements on the
market, based on the powerful R&D capability and high-quality
R&D resources of Chinese Academy of Sciences.
The Group adheres to the enterprise spirit of “dedication to
pharmaceutical and pursuit of excellence” and the core value of
“responsibility, humanism, harmony and gratitude”, bases itself on
corporate style of “dedication, conscientiousness, innovation and
accountability” and the significant opportunities for medical and
health-care development, sticks to innovation and development, and
devotes itself to creating China’s top-notch and internationally
known medical & heath-care group.
